Clinical Trial Update: Study of Pathophysiology of Status Epilepticus and Dysimmune Encephalitis [NA]

View source ↗

Summary

Clinical trial NCT04421846 investigates the pathophysiology of status epilepticus and dysimmune encephalitis and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dysimmune Encephalitis
• Status Epilepticus

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Status Epilepticus, Dysimmune Encephalopathy | NA | Status: RECRUITING